Barriga, Danver Kayle .

HRN: 23-82-24  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/01/2023
MEBENDAZOLE 100MG/5ML, 60ML SUSPENSION
10/01/2023
10/03/2023
PO
5ml
BID
Ascariasis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: